News Daily News Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review Todd Neale December 28, 2022
News Daily News Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women L.A. McKeown November 21, 2022
News Conference News EACTS 2022 Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG Michael O'Riordan October 12, 2022
News Daily News Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes Michael O'Riordan September 13, 2022
News Daily News CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES Michael O'Riordan July 22, 2022
News Industry News Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy July 20, 2022
News Daily News INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease Michael O'Riordan July 12, 2022
News Daily News Postop AF Portends Higher Risk of HF Hospitalization in the Next Few Years Caitlin E. Cox June 30, 2022
News Daily News Lower 10-Year Mortality With Multiple Arterial CABG in Diabetes: ART Yael L. Maxwell June 28, 2022
News Daily News Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off Yael L. Maxwell June 16, 2022
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Daily News PCI and CABG Are Complementary Options for Left Main CAD, Say Experts Michael O'Riordan April 27, 2022
News Daily News Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities Michael O'Riordan April 25, 2022
News Daily News Revascularization’s Benefits in HFrEF Linked to Gains in LV Function Caitlin E. Cox April 15, 2022
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Conference News ACC 2022 Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years Michael O'Riordan April 04, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022